Israel Englander Eli Lilly & CO Put Options Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $192 Million - $238 Million	-248,300 Reduced 39.12%	386,400 $342 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $152 Million - $190 Million	209,100 Added 49.13%	634,700 $575 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $17.1 Million - $22.8 Million	28,800 Added 7.26%	425,600 $331 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $115 Million - $135 Million	-218,300 Reduced 35.49%	396,800 $231 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $180 Million - $241 Million	514,600 Added 512.04%	615,100 $288 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $190 Million - $223 Million	-612,600 Reduced 85.91%	100,500 $34.5 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $71.6 Million - $83.5 Million	222,800 Added 45.44%	713,100 $261 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $2.61 Million - $2.97 Million	-8,800 Reduced 1.76%	490,300 $159 Million

4,003

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.